SBIR/STTR Research Award
DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS.
Award amount
$1,497,384Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AVANTGEN INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- WLNHKNPNT2M7
- Solicitation number
- PHS 2024-1
- Topic code
- 129
Research abstract
Development of rabbit monoclonal antibodies for Ferret biomarkers
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR INDIAN FLYING FOX (BAT) BIOMARKERS
- A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
- DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS
- DEVELOPMENT OF RAPID AND POINT-OF-CARE DIAGNOSTIC KIT FOR HEPATITIS C VIRUS DETECTION
- TOPIC 372:DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF NOVEL THERAPEUTICS
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- AFFINITY REAGENTS FOR THE IMMUNE SYSTEM OF GUINEA PIGS IL1B, IL2, IL4, IL6, IL8, IL10, IL12, AND IL13.
- REAGENTS FOR IMMUNOLOGIC ANALYSIS OF COTTON RAT.
- FURTHER CHARACTERIZATION AND VALIDATION OF MONOCLONAL ANTIBODIES TO STUDY RESPIRATORY
Research funding history
24 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $14,979,724. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services